Author: MacPherson, Amanda; Kimmelman, Jonathan
Description: The process of developing new and complex stem-cell-based therapeutics is incremental and requires decades of sustained collaboration among different stakeholders. In this Perspective, we address key ethical and policy challenges confronting the clinical translation of stem-cell-based interventions (SCBIs), including premature diffusion of SCBIs to clinical practice, assessment of risk in trials, obtaining valid informed consent for research participants, balanced and complete scientific reporting and public communications, regulation, and equitable access to treatment. We propose a way forward for translating these therapies with the above challenges in mind.
Subject headings: Clinical Trials as Topic; Ethics, Research; Health Care Costs; Humans; Informed Consent; Prospective Studies; Stem Cell Transplantation: Economics; Legislation & jurisprudence
Publication year: 2019
Journal or book title: Nature medicine
Volume: 25
Pages: 1037-1044
Find the full text: https://www.nature.com/articles/s41591-019-0511-6
Find more like this one (cited by): https://scholar.google.com/scholar?cites=14623759371775500967&as_sdt=1000005&sciodt=0,16&hl=en
Serial number: 3465